View Older Stories View More Recent Stories

Nov 30, 2018 04:00PM Amgen And UCB Announce FDA Advisory Committee Meeting To Review EVENITY™ (romosozumab) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture
Nov 28, 2018 04:00PM Amgen To Webcast Investor Call At ASH 2018
Nov 21, 2018 04:00PM Amgen To Present At the Piper Jaffray And Evercore ISI Healthcare Conferences
Nov 16, 2018 09:03AM Amgen (AMGN) Receives CHMP Positive Opinion To Expand Use Of BLINCYTO In Patients With Minimal Residual Disease-Positive B-Cell Precursor ALL
Nov 16, 2018 09:00AM Amgen Receives CHMP Positive Opinion To Expand Use Of BLINCYTO® (Blinatumomab) In Patients With Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia
Nov 12, 2018 04:04PM Amgen (AMGN) Highlights Long-Term Safety & Efficacy Results for Repatha (Evolocumab) in Longest Duration Study of a PCSK9 Inhibitor
Nov 12, 2018 04:00PM Amgen Presents Results Highlighting The Long-Term Safety And Efficacy Of Repatha® (Evolocumab) In The Longest Duration Study Of A PCSK9 Inhibitor To Date At AHA Scientific Sessions 2018
Nov 12, 2018 09:00AM Amgen Foundation Pledges $500,000 In Relief To Victims Of Ventura And Los Angeles County Wildfires
Nov 5, 2018 04:00PM Amgen Announces Presentation Of Research Reinforcing The Long-Term Safety And Efficacy Of Repatha® (Evolocumab) In High-Risk Patients At AHA Scientific Sessions 2018
Nov 5, 2018 09:04AM Amgen (AMGN), Provention Bio (PRVB) Announce Co-Development Collaboration In Celiac Disease
Nov 5, 2018 09:00AM Amgen And Provention Bio Announce Co-Development Collaboration In Celiac Disease
Nov 1, 2018 04:00PM Amgen To Present New Data Showcasing Extensive Portfolio And Exciting Early Oncology Pipeline At ASH 2018
Nov 1, 2018 09:00AM Amgen Foundation Deepens Commitment To Aspiring Scientists Worldwide By Expanding Amgen Scholars Program
Nov 1, 2018 07:11AM From pharma to prisons, election-sensitive stocks that could swing
Oct 30, 2018 04:01PM Amgen Reports Third Quarter 2018 Financial Results
Oct 26, 2018 07:54PM Amgen Announces New FOURIER Analysis Showing Benefit With Repatha® (Evolocumab) In High-Risk Patients With Established Cardiovascular Disease And Chronic Kidney Disease
Oct 26, 2018 04:00PM Amgen Announces Webcast Of 2018 Third Quarter Financial Results
Oct 24, 2018 04:54PM Amgen (AMGN) Makes Repatha Available in the US At 60% Reduced List Price
Oct 24, 2018 04:00PM Amgen Makes Repatha® (Evolocumab) Available In The US At A 60 Percent Reduced List Price
Oct 24, 2018 09:08AM Amgen (AMGN) Says Trial of TNF Inhibitor Versus Methotrexate Monotherapy in PsA Shows ENBREL Monotherapy and Combination Therapy Both Superior to Methotrexate
Oct 24, 2018 09:00AM First Head-to-Head Trial of a TNF Inhibitor Versus Methotrexate Monotherapy in Psoriatic Arthritis Shows ENBREL® (Etanercept) Monotherapy and Combination Therapy Both Superior to Methotrexate
Oct 23, 2018 04:00PM Amgen Announces 2018 Fourth Quarter Dividend
Oct 18, 2018 09:03AM Amgen (AMGN) Announces $66M Equity Investment in Oxford Nanopore Technologies
Oct 18, 2018 09:00AM Amgen Invests £50 Million ($66 Million) In Oxford Nanopore Technologies
Oct 17, 2018 09:01AM Express Scripts (ESRX) Announces New Value-Based Program for Migraine
Oct 16, 2018 05:50AM Amgen (AMGN) Announces Launch of AMGEVITA (Biosimilar Adalimumab) Across Europe
Oct 16, 2018 12:00AM Amgen Launches AMGEVITA™ (Biosimilar Adalimumab) In Markets Across Europe
Oct 1, 2018 09:01AM Amgen (AMGN) Says FDA Approved KYPROLIS Once-Weekly 70 mg/m2 In Combination With Dexamethasone For Patients With R/R Multiple Myeloma
Oct 1, 2018 09:00AM FDA Approves KYPROLIS® (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone (Kd70) For Patients With Relapsed Or Refractory Multiple Myeloma
Sep 24, 2018 09:00PM BLINCYTO® (blinatumomab) Approved In Japan For The Treatment Of Relapsed Or Refractory B-cell Acute Lymphoblastic Leukemia
Sep 20, 2018 09:00AM Amgen And Los Angeles County Announce Collaboration To Support Life Science Innovation Hub - BioLA
Sep 17, 2018 04:30PM World's Largest Alzheimer's Survey Reveals Most Adults Believe a Cure Will be Developed in Their Lifetime
Sep 11, 2018 04:00PM Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference
Sep 7, 2018 04:00PM Amgen To Present At The Morgan Stanley Global Healthcare Conference
Sep 7, 2018 02:00AM Tezepelumab Granted Breakthrough Therapy Designation By US FDA For The Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype
Sep 6, 2018 01:01AM Biocartis Group NV: BIOCARTIS ANNOUNCES H1 2018 RESULTS
Sep 6, 2018 01:00AM Biocartis Group NV: BIOCARTIS ANNOUNCES H1 2018 RESULTS
Sep 5, 2018 09:00AM Amgen And LabCentral Open Nomination Process For Lab Residency
Aug 29, 2018 09:03AM Amgen (AMGN) Says EC Approves BLINCYTO For Use In Pediatric Patients With Philadelphia Chromosome-Negative R/R B-Cell Precursor ALL
Aug 29, 2018 09:00AM European Commission Approves BLINCYTO® (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Aug 27, 2018 09:03AM Amgen (AMGN) Submits Supplemental NDA For KYPROLIS Once-Weekly 70 mg/m2 In Combination With Dexamethasone
Aug 27, 2018 09:00AM Amgen Submits Supplemental New Drug Application For KYPROLIS® (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone
Aug 21, 2018 08:00AM Amgen To Present Robust Data Exploring The Impact Of Treatment With Repatha® (evolocumab) Across Patient Subgroups And High-Risk Populations At ESC Congress 2018
Jul 31, 2018 04:15PM Amgen Breaks Ground On Next-Generation Biomanufacturing Plant In Rhode Island
Jul 31, 2018 04:00PM Amgen Announces 2018 Third Quarter Dividend
Jul 26, 2018 04:02PM Amgen Announces Succession Plans For Two Executive Officers
Jul 26, 2018 04:01PM Amgen Reports Second Quarter 2018 Financial Results
Jul 24, 2018 04:00PM Amgen Announces Webcast of 2018 Second Quarter Financial Results
Jul 20, 2018 04:26PM Pfizer (PFE) Announces FDA Approves for its Neupogen Biosimilar NIVESTYM
Jul 19, 2018 04:00PM Amgen And Cedars-Sinai Partner For Improved Healthcare Quality
View More Recent Stories View Older Stories